Suchergebnisse - "Schwartz, Lisa M"

PubPharm (260)

1

Case Report : It's a Small Whirl Afterall

enthalten in: Journal of education & teaching in emergency medicine | 2022

von Schwartz, L. | Perdomo, R. | An, J.

2

A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care

enthalten in: JAMA internal medicine | 2020

von King, A. | Schwartz, L. | Woloshin, S.

CommentIn: JAMA Intern Med. 2020 Apr 1;180(4):595-596. - PMID 31985770

3

Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion

enthalten in: Circulation. Cardiovascular quality and outcomes | 2019

von Schwartz, L. | Woloshin, S. | Lu, Z. | +4

4

Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing

enthalten in: JAMA internal medicine | 2019

von Kesselheim, A. | Woloshin, S. | Lu, Z. | +3

CommentIn: JAMA Intern Med. 2019 May 1;179(5):709-710. - PMID 30667458

5

Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012 : a Cross-Sectional Analysis

enthalten in: Journal of general internal medicine | 2019

von Wallach, J. | Egilman, A. | Ross, J. | +2

6

Trends in Testosterone Prescribing for Age-related Hypogonadism in Men With and Without Heart Disease

enthalten in: JAMA internal medicine | 2019

von Morden, N. | Woloshin, S. | Brooks, C. | +1

CommentIn: J Urol. 2019 Jun;201(6):1037. - PMID 30888894

7

Internal Medicine Physicians' Financial Relationships with Industry : An Updated National Estimate

enthalten in: Journal of general internal medicine | 2019

von Kesselheim, A. | Woloshin, S. | Lu, Z. | +3

8

Visual Representations of Risk Enhance Long-Term Retention of Risk Information : A Randomized Trial

enthalten in: Medical decision making : an international journal of the Society for Medical Decision Making | 2019

von Arrick, B. | Bloch, K. | Colello, L. | +2

9

Medical Marketing in the United States, 1997-2016

enthalten in: JAMA | 2019

von Schwartz, L. | Woloshin, S.

CommentIn: JAMA. 2019 Jan 1;321(1):40-41. - PMID 30620354

10

Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis

enthalten in: Journal of general internal medicine | 2018

von Wallach, J. | Egilman, A. | Ross, J. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]